GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Molekule Group Inc (OTCPK:MKULQ) » Definitions » Enterprise Value

Molekule Group (Molekule Group) Enterprise Value : $41.90 Mil (As of Apr. 29, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Molekule Group Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Molekule Group's Enterprise Value is $41.90 Mil. Molekule Group's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was $-42.28 Mil. Therefore, Molekule Group's EV-to-EBIT ratio for today is -0.99.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Molekule Group's Enterprise Value is $41.90 Mil. Molekule Group's EBITDA for the trailing twelve months (TTM) ended in Jun. 2023 was $-41.01 Mil. Therefore, Molekule Group's EV-to-EBITDA ratio for today is -1.02.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Molekule Group's Enterprise Value is $41.90 Mil. Molekule Group's Revenue for the trailing twelve months (TTM) ended in Jun. 2023 was $21.74 Mil. Therefore, Molekule Group's EV-to-Revenue ratio for today is 1.93.


Molekule Group Enterprise Value Historical Data

The historical data trend for Molekule Group's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Molekule Group Enterprise Value Chart

Molekule Group Annual Data
Trend Dec19 Dec20 Dec21 Dec22
Enterprise Value
- - 125.67 28.08

Molekule Group Quarterly Data
Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 172.69 18.71 28.08 91.80 121.56

Competitive Comparison of Molekule Group's Enterprise Value

For the Pollution & Treatment Controls subindustry, Molekule Group's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Molekule Group's Enterprise Value Distribution in the Industrial Products Industry

For the Industrial Products industry and Industrials sector, Molekule Group's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Molekule Group's Enterprise Value falls into.



Molekule Group Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Molekule Group's Enterprise Value for the fiscal year that ended in Dec. 2022 is calculated as

Molekule Group's Enterprise Value for the quarter that ended in Jun. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Molekule Group  (OTCPK:MKULQ) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Molekule Group's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=41.904/-42.277
=-0.99

Molekule Group's current Enterprise Value is $41.90 Mil.
Molekule Group's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-42.28 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Molekule Group's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=41.904/-41.007
=-1.02

Molekule Group's current Enterprise Value is $41.90 Mil.
Molekule Group's EBITDA for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-41.01 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Molekule Group's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=41.904/21.741
=1.93

Molekule Group's current Enterprise Value is $41.90 Mil.
Molekule Group's Revenue for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $21.74 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Molekule Group Enterprise Value Related Terms

Thank you for viewing the detailed overview of Molekule Group's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Molekule Group (Molekule Group) Business Description

Traded in Other Exchanges
N/A
Address
10455 Riverside Drive, Palm Beach Gardens, FL, USA, 33410
Molekule Group Inc is an interior space air purification technology company with an immediate objective of initiating full-scale commercialization of its high-performance interior air sterilization and disinfection products for the eradication of coronavirus and other harmful airborne pathogens. The Company was established to develop technology-driven, medical-grade air purification solutions for hospitals and other healthcare settings. Its air hygiene product, Purgo, is an FD medical device that provides continuous air filtration, sanitization, and supplemental ventilation solutions with technology that can be applied in any indoor space including in hospitals, offices, and even in elevators.
Executives
Ritankar Pal officer: Chief Operating Officer 10455 RIVERSIDE DR., PALM BEACH GARDENS FL 33410
Jonathan Harris officer: Chief Commercial Officer 3000 CLEARVIEW WAY, SAN MATEO CA 94402
Bradley A Feld director C/O FOUNDRY GROUP, 645 WALNUT ST., BOULDER CO 80302
Ryan A Mcintyre 10 percent owner
Seth Levine 10 percent owner 1050 WALNUT STREET, SUITE 210, BOULDER CO 80302
Fg Next Gp, Llc 10 percent owner 1050 WALNUT STREET, SUITE 210, BOULDER CO 80302
Foundry Group Next, L.p. 10 percent owner C/O FOUNDRY GROUP, 1050 WALNUT STREET, SUITE 219, BOULDER CO 80302
Ward Jr Stephen M director C/O CARPENTER TECHNOLOGY CORP, PO BOX 14662, READING PA 19612
Timothy J Scannell director 2825 AIRVIEW BOULEVARD, KALAMAZOO MI 49002
Heather Floyd director 1300 CORPORATE CENTER WAY, WELLINGTON FL 33414
Thomas P Mccaffrey director 1300 CORPORATE CENTER WAY, WELLINGTON FL 33414
Lewis C Pell 10 percent owner C/O VISION SCIENCES INC, 6 STRATHMORE RD, NATICK MA 01760
Michael F Senft director 1300 CORPORATE CENTER WAY, WELLINGTON FL 33414
Jason Dibona officer: Chief Executive Officer 10455 RIVERSIDE DRIVE, PALM BEACH GARDEN FL 33410
David Helfet director 10455 RIVERSIDE DRIVE, PALM BEACH GARDENS FL 33410

Molekule Group (Molekule Group) Headlines

From GuruFocus

AeroClean Reports Second Quarter 2022 Financial Results

By PurpleRose PurpleRose 08-16-2022

AeroClean Technologies and Molekule Announce the Close of All-Stock Merger

By Stock market mentor Stock market mentor 01-12-2023